Home / Recalls / Pfizer Us Pharmaceutical Group / D-1328-2014

D-1328-2014 Class I Terminated

Recalled by Pfizer Us Pharmaceutical Group — New York, NY

Recall Details

Product Type
Drugs
Report Date
May 28, 2014
Initiation Date
March 6, 2014
Termination Date
May 10, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
49,847 bottles

Product Description

Effexor XR (venlafaxine HCl) Extended-Release Capsules, 150 mg, packaged in a) 30-count Unit of Use bottles (NDC 0008-0836-21) UPC 3 0008-0836-21 7; b) 90-count Unit of Use bottles (NDC 0008-0836-22) UPC 3 0008-0836-22 4; Rx only, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA 19101.

Reason for Recall

Presence of Foreign Tablets/Capsules: A Pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach colored capsule printed TKN250 which was identified as a Tikosyn (dofetilide) capsule.

Distribution Pattern

Nationwide and Puerto Rico

Code Information

Lot #: a) V130142, Exp 10/15; b) V130140, Exp 10/15

Other recalls by Pfizer Us Pharmaceutical Group

  • D-1409-2014 Class II — Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg, 30 count bottle, Rx onl (April 16, 2014)
  • D-1166-2014 Class III — Advil PM Caplets, (Ibuprofen, 200 mg /Diphenhydramine citrate, 38 mg) 120 count (February 26, 2014)
  • D-014-2014 Class II — Aldactone (spironolactone) tablets, USP, 100 mg, 100-count bottles, Rx only, Dis (September 4, 2013)